2022 INIM Conference
Join the Institute for Neuro-Immune Medicine (Nova Southeastern University) on Friday, June 10th for their annual 2022 INIM Conference. The Institute’s clinicians and researchers will discuss research and the various […]
AIM ImmunoTech Announces Update on Ampligen Long Covid Development Program
Today, AIM ImmunoTech, an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, provided an update […]
Solve M.E. Announces Worldwide Launch of Long Haul Voices: Living with Long Covid and ME/CFS in Honor of World ME Day 2022
https://www.youtube.com/watch?v=W_UFlzaNU6g&list=PLbO5abv0daLXDapXhiaVgeDJaIU66DRDA&index=1 New and timely series will amplify the experiences of individuals with Long Covid and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) to improve care and increase understanding Today, in honor of […]
Long Covid and Children
The Global Interdependence Center – Solve Long Covid Initiative Program Series: Session III: Long Covid and Children. The Global Interdependence Center, in partnership with the Solve Long Covid Initiative, is conducting a […]
Solve M.E. CEO Oved Amitay and Dr. Leonard Jason Write Letter to the Editor, Nature
DePaul Univeristy Professor of Psychology Leonard Jason, PhD and Solve M.E. President and CEO Oved Amitay recently co-authored a response to a Nature article linking Epstein-Barr virus (EBV) and multiple […]
Long COVID & Fatiguing Illness Recovery Program ECHO
History of ME/CFS Lucinda Bateman, MD Medical Director, Provider, & Research expert in the diagnosis and treatment of ME/CFS. Founder and Chief Medical Officer of the Bateman Horne Center of […]
Solve M.E Kicks Off Advocacy Month Highlighting Long Covid’s Widespread Impact, Spotlight on ME/CFS
Advocacy Month 2022 focuses on connecting people with ME/CFS, Long Covid, and other related illnesses—brings together scientists, clinicians, and caregivers to educate Congress and the world As the prevalence and […]
Trial By Error: Two Reports on the Financial Burden of Long Covid and Its Impact on ME/CFS Prevalence
This piece was originally published in Virology Blog by David Tuller, DrPH on April 20, 2022 and is republished here with permission. It is clear that long Covid—however that term […]
New York Times Cites Solve M.E Whitepaper, Quotes VP of Advocacy Emily Taylor
This week, New York Times writer Peter Coy’s piece, “Pushing ‘Long Covid’ Sufferers Too Hard Could Cause Them to Crash,” cited our recently released whitepaper, Long Covid’s impact on adult […]
Ask Congress to TREAT & CARE for Post-Infection Diseases During Advocacy Month
Advocacy Month is an opportunity to share the policy solutions vital to address the growing number of individuals suffering from ME/CFS and Long Covid. ME/CFS devastated the lives of an […]
Solve M.E. co-authors whitepaper “Long Covid Impact on Adult Americans: Early Indicators Estimating Prevalence and Cost”
This week, Solve M.E. invited members of the press to a special event announcing the release of our new whitepaper, Long Covid Impact on Adult Americans: Early Indicators Estimating Prevalence […]
Bloomberg Law exclusive reports Solve M.E.-funded data on the devastating impact of Long Covid
The need for official data from the Centers for Disease Control (CDC) is crucial to the study of Long Covid, as well as the effort to fund the Long Covid […]
